FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064026 [Registered on: 12/03/2024] Trial Registered Prospectively
Last Modified On: 15/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate the efficacy of Kalyanaka kshara and Vidangadi Gutika along with Shwadanshtradi kwath after Koshtha Shodhana in the Management of Mutrashmari (Urolithiasis) 
Scientific Title of Study   A Comparative Clinical study to evaluate the efficacy of Kalyanaka kshara and Vidangadi Gutika along with Shwadanshtradi kwath after Koshtha Shodhana in the Management of Mutrashmari (Urolithiasis). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vidhi Jain 
Designation  Post Graduate Resident 
Affiliation  All India Institute Of Ayurveda 
Address  C Block, 6th Floor,Room No. 618 Department Of Kayachikitsa , All India Istitute Of Ayurveda, Sarita Vihar , New Delhi

South
DELHI
110076
India 
Phone  9868386792  
Fax    
Email  vdvidhijainaiia@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Proff. Dr. Jonah Sandrepogu 
Designation  Head Of Departement 
Affiliation  All India Institute Of Ayurveda 
Address  C-Block, 6th Floor Room No. 617,Department Of Kayachikitsa, All India Institute Of Ayurveda ,Mathura Road, Gautampuri, Sarita Vihar

South
DELHI
110076
India 
Phone  9448262298  
Fax    
Email  jonahdr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Proff. Dr. Jonah Sandrepogu 
Designation  Head Of Department 
Affiliation  All India Institute Of Ayurveda 
Address  C-Block, 6th Floor, Room No. 617 ,Department Of Kayachikitsa, All India Institute Of Ayurveda ,Mathura Road, Gautampuri, Sarita Vihar

South
DELHI
110076
India 
Phone  9448262298  
Fax    
Email  jonahdr@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda 
 
Primary Sponsor  
Name  All India Institute Of Ayurveda 
Address  All India Institute Of Ayurveda ,Mathura Road, Gautampuri, Sarita Vihar , New delhi-110076  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vidhi Jain  All India Institute Of Ayurveda   C-Block, 6th Floor,Room No.618 ,Department Of Kayachikitsa, All India Institute Of Ayurveda ,Mathura Road, Gautampuri, Sarita Vihar
South
DELHI 
9868386792

vdvidhijainaiia@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Division Of Translational Research And Biostatistics  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N20-N23||Urolithiasis. Ayurveda Condition: MUTRAVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Kalyanaka khasra, Reference: Ashtang Hridaya chikitsa sthan 8/140-143, Route: Oral, Dosage Form: Kshara , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 42 Days, anupAna/sahapAna: Yes(details: -Go Ghrita), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Vidangadi Gutika, Reference: Abhinava Chintamani 37 kiran/ 12-13, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 42 Days, anupAna/sahapAna: Yes(details: -Lukewarm Water), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Kidney stone size up to 10 mm and/or
2. Ureteric Stone size up to 8 mm and/or
3. Urinary Bladder Stone size up to 10 mm.
4. Radiographic and /or USG evidence of the stone.  
 
ExclusionCriteria 
Details  1. Chronic Renal failure.
2. Gross Hydronephrosis.
3. Cases which require surgical intervention.
4. Severe Hematuria.
5. Kidney stone and Bladder Stone size more than 10 mm.
6. Ureteric stone Size more than 8 mm
7. Known cases of Malignancy, Tuberculosis.
8. Known cases of HIV (Human Immunodeficiency Virus), VDRL (Venereal Disease Research Laboratory) and
Hepatitis-B positive.
9. Patients with HbA1C ≥ 9 And Grade 3 hypertension: SBP greater than or equal to 180mmHg and/or DBP
greater than or equal to 110mmHg.
10. Patients with previously known allergy of any of the interventional drugs or ingredients.
11. Patients not willing for trial and follow up. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
80% Reduction In The Symptoms Of Mutrashmari  0th Day , 14th Day ,28th Day , 43rd Day 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction In The Size Of Stone  0th Day AND 43rd Day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patient suffering from HTN, DM, asthma, and anaesthetic drugs sensitivity etc needs some alternative management to avoid surgical procedures. These factors invite the need of an effective medicinal treatment for urolithiasis with least chances of recurrence. Though different Aachaaryas have been described use of various medicines along with the Kshaara Dravyas, Kwathas, Ras aushadhis, etc. No work is done on the concept of Koshtha shodhana followed by Shwadanshtradi kwath  ( RefBhaishajya ratnavali ashmari chikitsa) with Kalyanaka kshara and with Vidangadi Gutika. Also, usage of Kalyanaka Kshara(as mentioned in its Phal shruti in Ashtanga Hridaya Arsha chikitsa) in Mutrashmari is not explored. Vidangadi Gutika mentioned in “Abhinava Chintamani – Ashmari Chikitsa” vii is undertaken in this research study as it is an unexplored formulation. In the study kshara was selected due to its multiple properties Chedana (Excision), Bhedana (Incision), Lekhana (Scraping), Shodhana (Cleaning), Ropana (Healing) etc.  
Close